There is a form of clinical education that does not happen in classrooms or textbooks or even in fellowship training programs. It happens slowly, across years of practice, in the space between what the protocol predicted and what the patient's biology actually did.
It is the education of failure.
Not personal failure — the failure of professional judgment or clinical care. But the clinical reality of cases that did not work the way they should have. Cycles that failed despite apparently good embryos and adequate preparation. Couples who carried every prognostic indicator of success and then did not succeed. Diagnoses that were correct by standard assessment and yet incomplete in the way that mattered most.
Every fertility doctor who has practiced long enough and widely enough has encountered this education. The question is what they do with it. Whether each case that does not go as expected is filed away as an unfortunate outlier, or whether it is interrogated — examined carefully, questioned thoroughly, used as the foundation of a better clinical question than the one that was asked before.
I want to describe what this education has produced in my own thinking — what specifically I have learned from the cases that did not work, how those lessons have changed what I investigate, what I assume, and what I refuse to accept as a settled conclusion. Because the thinking that guides a fertility specialist's approach to difficult cases is shaped, more than anything else, by how seriously that specialist has engaged with the cases that taught them the limits of what they previously understood.
The First Lesson: Normal Does Not Mean Adequate
Early in any fertility practice, the framework of normal and abnormal is clear and reassuring. Tests return results. Reference ranges establish what is normal. Findings within those ranges are documented as normal and effectively removed from the clinical picture. The investigation proceeds to the next parameter.
This framework is useful. It is also, in complex cases, dangerously incomplete.
The most important lesson that failure cases teach a fertility doctor — the lesson that changes clinical thinking at the most fundamental level — is that normal does not mean adequate. That a result within the reference range does not mean that parameter is not contributing to the failure. That the reference range was established for the general population, not for the specific clinical context of IVF, and that the threshold at which a parameter begins to affect IVF outcomes may be different from the threshold at which it is classified as abnormal by general laboratory standards.
The clearest example in my practice is thyroid function. The TSH reference range in most Indian laboratories extends from 0.5 to 4.5 or 5.0 mIU/L. A TSH of 3.8 mIU/L is within this range. It is reported as normal. The previous clinic, seeing a normal TSH, moves on to the next parameter.
What the failure cases taught me — through the pattern of women with TSH in the 3.0 to 4.5 range whose IVF cycles repeatedly failed, and whose subsequent cycles after TSH optimization to below 2.5 mIU/L succeeded — is that the fertility-specific threshold is different from the general laboratory threshold. A TSH that is normal by laboratory standards may be suboptimal for the hormonal environment of IVF. The previous clinic was not wrong to note the TSH was normal by their reference range. They were wrong to treat that classification as the end of the thyroid conversation rather than the beginning of a more specific question.
Sperm DNA fragmentation carries the same lesson at a more profound level. The standard semen analysis has no DFI component. A result described as normal by the standard analysis is normal by the criteria the analysis measures — count, motility, morphology. It says nothing about DNA integrity. The reference range for DFI does not appear in a standard semen analysis because DFI is not measured in a standard semen analysis.
The failure cases — the couples whose embryos consistently failed to develop beyond day three, whose blastocyst rates were consistently lower than the egg number predicted, whose transfers consistently failed despite morphologically good embryos — taught me that the male investigation was never complete when it stopped at the standard analysis. That normal by the measured parameters is not the same as normal by the unmeasured ones. And that the unmeasured ones may be the ones that matter most.
The Second Lesson: What the Cycle Is Telling You Is More Important Than the Protocol
Protocols in IVF are derived from evidence — from studies of populations of patients, from the accumulated clinical experience of many practitioners, from the refinement of approaches that work for the majority of well-described presentations. They are valuable. They are the starting point of every IVF cycle.
They are not the ending point. And failure cases teach this with particular clarity.
When a cycle fails, the failure carries clinical information. The specific stage at which the failure occurred — fertilization, early embryo development, blastocyst formation, implantation, early pregnancy — points toward specific causal domains. The quality of the embryos that were produced, assessed not just by grade but by the pattern of development across the culture period, carries information about what was working and what was not. The behavior of the endometrium across the preparation phase — how it developed, how it responded to estrogen, what the Doppler showed about its vascularity — carries information about the uterine environment and whether it was optimal.
Early in practice, the tendency is to treat failure as a signal to modify the protocol for the next cycle — to adjust the starting dose, to change the trigger timing, to add a supplement. The protocol is modified at the margins. The underlying framework remains intact.
What failure cases teach — through the specific pattern of what the cycle showed and what the protocol did not address — is that the modification should follow the information. That the cycle is speaking, in clinical language, about what was inadequate. And that the clinical task is to listen to what the cycle is saying and respond to it specifically, not to apply a pre-determined adjustment that was not informed by the cycle's specific findings.
A cycle that produced twelve eggs but only four mature eggs at the time of retrieval is telling you something about the trigger timing or the stimulation profile that did not match this patient's specific follicular development pattern. A cycle that fertilized eight eggs but produced only two blastocysts that arrested on day three is telling you something about the developmental competence of the embryos that is different from a cycle that produced six blastocysts and transferred two.
The failure cases taught me to read the cycle — to treat its specific findings as the most accurate biological information available about how this patient's fertility responds to medical intervention — and to design the next cycle as a response to what the previous cycle revealed, rather than as a repetition of a protocol that was designed before the cycle had anything to say.
The Third Lesson: The History Contains the Diagnosis
One of the most consistent findings across years of evaluating failure cases is that the information needed to understand why the case has been failing is, very frequently, present in the clinical history before any additional test is ordered.
Not always. Sometimes the diagnosis requires a test that has not yet been performed. But more often than is generally appreciated, the clinical history — taken carefully enough, and with the right questions — contains the signal that points directly toward the cause.
The patient who mentions, almost in passing, that her periods became lighter after a postpartum procedure. The patient who describes an IVF cycle where her estrogen rose unusually rapidly during stimulation — a pattern consistent with an undiagnosed varicocele-associated hormonal environment in the male partner. The patient whose two previous cycles both failed shortly after implantation was confirmed, at the same gestational week — a pattern more consistent with a treatable cause of early pregnancy loss than with random embryonic failure.
These signals are present in the history. They emerge when the history is taken with the specific intent of finding them — not as a form-filling exercise, but as a clinical conversation in which each answer generates the next question and in which the doctor is actively building a picture rather than passively recording information.
What failure cases teach is that this kind of history-taking is not a luxury. It is the most efficient form of diagnosis available — because it directs the subsequent investigation toward the area most likely to be productive. Every test ordered in the absence of a clinical hypothesis that prompted its ordering is a test ordered blind. The history provides the hypothesis. The test confirms or refutes it.
I spend more time on the clinical history at Metro IVF than I have seen spent on it at any other fertility clinic — because failure cases have taught me that the time is always repaid in diagnostic yield. The detail that changes the direction of the investigation is almost never in the initial summary. It is in the layer beneath — in the question that the summary generates, answered by a patient who has rarely been asked.
The Fourth Lesson: The Couple Who Has Failed the Most Deserves the Most Thorough Investigation
There is a clinical tendency — understandable, but clinically counterproductive — to apply less investigative effort to cases that appear hopeless than to cases that appear straightforward. The couple who has failed five times, with severely compromised fertility parameters, may seem to warrant a brief consultation and a frank prognosis conversation rather than the full investigation that a new, more promising case would receive.
This tendency inverts the clinical priority.
The couple who has failed the most times is the couple who most needs a thorough investigation — precisely because they have accumulated the most clinical information about what has not worked, and precisely because the probability that the investigation will find something actionable is, in my experience, substantially higher in cases with multiple failures than in cases with none.
Every failed cycle is a data point. A couple who has failed five times has five data points about what their fertility does when managed in a specific way. Five opportunities to look at the cycle data and identify, with more specificity than a single failure allows, where the process consistently breaks down and why.
The failure cases taught me this lesson through the cases that most other clinics had concluded were finished. The couple told that nothing more could be done whose thorough re-evaluation identified a displaced implantation window that had caused every previous transfer to be systematically mistimed. The man with azoospermia who had been told biological fatherhood was impossible and whose surgical assessment found sperm in a testicular region that had never been sampled. The woman with severely diminished reserve whose natural cycle protocol produced an egg of better quality than any of the high-dose stimulation cycles that preceded it.
The thoroughness of the investigation must be proportional to the difficulty of the case — not inversely proportional to it. The most difficult cases deserve the most thorough investigation. And that investigation, applied with the clinical knowledge and diagnostic instinct that failure cases teach over years of practice, finds something actionable more often than the prior clinical conclusion suggested was possible.
The Fifth Lesson: Honesty Is Not Discouragement. It Is the Foundation of Real Hope.
Perhaps the most personal lesson that failure cases teach — and the one that most directly affects how I communicate with patients — is about the relationship between honesty and hope.
Early in a career, there is a natural tendency to frame clinical information in the most encouraging terms available. To emphasize the possibilities rather than the limitations. To describe success rates at their upper range rather than their median. To avoid the conversation about donor eggs or about the limits of what autologous IVF can achieve, because that conversation is difficult and the patient has come hoping for reassurance.
What failure cases teach — through the cases where false reassurance delayed the transition to a more appropriate treatment path, through the couples who spent two additional years on autologous IVF that the clinical evidence could not support, through the grief that accumulates around a false hope that eventually has to be corrected — is that honesty and hope are not in opposition.
The couple who receives an honest assessment of their specific clinical situation — who is told, with compassion and specificity, what the investigation shows and what it means for their prognosis — is not a couple whose hope has been extinguished. They are a couple who can now make genuinely informed decisions about what to do next. They can decide whether to pursue another autologous cycle with the understanding of what the probability looks like. They can explore donor egg IVF with the knowledge that it offers meaningfully better success rates for their specific situation. They can make the decision to stop treatment — if that is the right decision — with the certainty that they did not stop before the investigation was complete.
The hope that failure cases teach me to offer is not the hope of false reassurance. It is the hope that comes from the most accurate clinical picture available — from knowing, with the best evidence medicine can currently provide, where you stand and what remains possible. That kind of hope is built on truth. And truth, however difficult, is more durable than reassurance that eventually has to be withdrawn.
What This Thinking Produces for the Couples Who Come to Metro IVF
The clinical thinking that years of failure cases have shaped — the willingness to question what is normal, to read the cycle, to take the history thoroughly, to invest the most investigative effort in the most difficult cases, and to offer honesty as a form of hope — produces a specific kind of clinical encounter at Metro IVF.
It is an encounter in which prior conclusions are questioned rather than accepted. In which investigation is proportional to complexity rather than inversely proportional to it. In which the history is taken as the most important diagnostic conversation rather than as the form to be completed before the real investigation begins. In which the specific findings of each failed cycle are used to design the next approach rather than to justify a repetition of the previous one.
And in which the couple sitting across the desk receives not a protocol applied to their diagnosis, but an assessment applied to them — specifically, individually, with the full weight of what years of difficult cases have taught about what investigations to prioritize, what patterns to recognize, and what questions to ask before any conclusion is reached.
This is what experience with failure cases produces in a fertility doctor's thinking. It is also, for the couples whose cases have been difficult and whose previous treatment has been insufficient, what they find at Metro IVF that they did not find before.
Metro IVF Test Tube Baby Center Ambikapur, Chhattisgarh metrofertility.in Led by Dr. Ashish Soni — North India's First Fertility Super Specialist
The doctor whose thinking has been shaped by the cases that were hardest. Book your consultation with Dr. Ashish Soni at Metro IVF today.